Pirates from Stevenson's KIDNAPPED by N.C. WyethWyeth's Ghostwritten Documents to be Unsealed
NYT article - PDF
Judge's order to unseal
And here is a news release regarding $22 Million payouts to doctors by Lilly: Link
Showing posts with label ghostwriting. Show all posts
Showing posts with label ghostwriting. Show all posts
Monday, August 3, 2009
Wyeth's Ghostwritten Documents to be Unsealed
Pirates from Stevenson's KIDNAPPED by N.C. WyethWyeth's Ghostwritten Documents to be Unsealed
NYT article - PDF
Judge's order to unseal
And here is a news release regarding $22 Million payouts to doctors by Lilly: Link
Saturday, June 13, 2009
Lilly ‘Ghostwrote’ Articles to Market Drug, Files Say
From Bloomberg: Link
Lilly ‘Ghostwrote’ Articles to Market Drug, Files Say (Update2)
By Elizabeth Lopatto, Jef Feeley and Margaret Cronin Fisk
June 11 (Bloomberg) -- Eli Lilly & Co. officials wrote medical journal studies about the antipsychotic Zyprexa and then asked doctors to put their names on the articles, a practice called “ghostwriting,” according to unsealed company files.
Lilly employees also compiled a guide to hiring scientists to write favorable articles, complained to journal editors when publication was delayed and submitted rejected articles to other outlets, according to documents filed in drug-overpricing suits against the Indianapolis-based company, the largest manufacturer of psychiatric medicines.
Drugmakers’ use of ghostwriters has created “a huge body of medical literature that society can’t trust,” said Carl Elliott, a University of Minnesota bioethicist who has written about the practice. "
Also see this article.
Lilly ‘Ghostwrote’ Articles to Market Drug, Files Say (Update2)
By Elizabeth Lopatto, Jef Feeley and Margaret Cronin Fisk
June 11 (Bloomberg) -- Eli Lilly & Co. officials wrote medical journal studies about the antipsychotic Zyprexa and then asked doctors to put their names on the articles, a practice called “ghostwriting,” according to unsealed company files.
Lilly employees also compiled a guide to hiring scientists to write favorable articles, complained to journal editors when publication was delayed and submitted rejected articles to other outlets, according to documents filed in drug-overpricing suits against the Indianapolis-based company, the largest manufacturer of psychiatric medicines.
Drugmakers’ use of ghostwriters has created “a huge body of medical literature that society can’t trust,” said Carl Elliott, a University of Minnesota bioethicist who has written about the practice. "
Also see this article.
Subscribe to:
Posts (Atom)
Posts
